A Phase III Study of Regional Radiation Therapy in Early Breast Cancer
Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.
Primary Sponsor
NCIC CTG
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
180
Trial Chairperson
International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua
Trial Contact
ymurray@ctg.queensu.ca
Clinical Trial Registration
Related Post
27 May, 2025
Intrepid trekkers to take on Kokoda Challenge for TROG
LATEST NEWS: 27 May 2025 A team of five
27 May, 2025
Clinical Trials Day celebrations help spread the work about TROG’s work
LATEST NEWS: 27 MAY 2025 TROG members and staff
